Anju Software has had a busy year, making three transactions public in the first three quarters of 2018. Its latest deal is for Zephyr Health, a San Francisco-based startup backed by Kleiner Perkins Caulfield & Byers, Icon Ventures and Google Ventures.
Anju, a life sciences software platform, is backed by Providence Equity Partners. Its integrated platform spans clinical, medical affairs and after-market solutions.
Zephyr provides comprehensive physician, institution and treatment data for every major disease area. It uses proprietary algorithms to link disparate data sources in an effort to deliver actionable insights.
This deal continues Anju’s strategy to combine robust software with actionable data for its customers, including pharmaceutical companies, clinical research organizations (CRO), agencies and medical device companies. It also expands Anju’s geographical footprint to San Francisco, London and Pune, India.
Prior to this announcement, Anju added MDCPartners, based in Antwerp, Belgium. MDCPartners specializes in business intelligence data solutions for clinical trial optimization, medical expert identification and competitive intelligence.
The acquisition allows Anju to provide end-to-end software solutions to help its customers manage pharma processes and turn data into–you guessed it–actionable insights.
Back in March, the company acquired Sylogent in Bristol, Pennsylvania. Sylogent provides software and business services to the pharmaceutical industry with a focus on information required to bring a product to market. It operates to ensure timely completion of critical information, maximize compliance goals and reduce risk management liability.
Financial terms were not disclosed in any of the deals.
